The CLL pipeline drugs market research report provides comprehensive information on the therapeutics under development for CLL
Ibrutinib can be used in the initial treatment of CLL. It has also been shown to help when CLL is hard to treat, for instance, if the CLL cells
Chronic lymphocytic leukaemia (CLL) Chronic lymphocytic leukaemia (CLL) is a type of blood cancer. It affects the blood and bone marrow. CLL affects the white blood cells called
New Patient Appointments Radiation Therapy for CLL Stem Cell Transplant for CLL Investigational Approaches Immunotherapy New Therapeutic Drugs Ongoing
Chronic lymphocytic leukemia (CLL): The most common chronic leukemia in adults, CLL occurs more frequently in men than women. Like ALL, CLL is also caused by the
Rituxan is a drug that was approved for CLL almost 10 years ago. Ibrutinib has been around for a few years and was first approved for CLL treatment in 2024.
How Long Will Remission Last With New CLL Drugs? How do new oral drugs affect CLL remission rates? Jennifer A. Woyach, MD, Associate Professor, Division of Hematology, The Ohio State University and Patient Power co-founder and CLL patient, Andrew Schorr discuss how new oral CLL medications affect remission rates and length.
CLL Advocate Network (CLLAN), a global network of CLL patient organizations including CLL Society, surveyed nonprofits around the world to understand what support services and resources are offered to individuals impacted by CLL / SLL. The information collected was used to build a global resource hub.
They work by targeting proteins on the surface of cancer cells. The B-cell receptor is a protein found on the surface of CLL cells. It controls how CLL cells grow. If the B-cell receptor is switched off, the CLL cells die. BCR inhibitors target the B-cell receptors to stop the cancer growing and dividing. The drugs that can be used for CLL are:
Comments